(Q42747102)

English

Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21381899%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21381899%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference

based on heuristic

inferred from title

Arun P Lakshmanan

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21381899%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

author name string

Kenichi Watanabe

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21381899%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Rajarajan A Thandavarayan

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21381899%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Flori R Sari

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21381899%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Meilei Harima

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21381899%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Vijayasree V Giridharan

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21381899%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Vivian Soetikno

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21381899%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Makoto Kodama

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21381899%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Yoshifusa Aizawa

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21381899%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

publication date

7 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21381899%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Free Radical Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21381899%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

45

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21381899%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21381899%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

575-584

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21381899%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Diabetic nephropathy and antihypertensive treatment: what are the lessons from clinical trials?

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Prevention of diabetic renal disease with special reference to microalbuminuria

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Angiotensin II as a mediator of tubulointerstitial injury

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Proinflammatory effects of angiotensin II and endothelin: targets for progression of cardiovascular and renal diseases

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Diabetic nephropathy: mechanisms of renal disease progression

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Telmisartan inhibits both oxidative stress and renal fibrosis after unilateral ureteral obstruction in acatalasemic mice.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Obstructive nephropathy and renal fibrosis

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Effects of AT1- and beta-adrenergic receptor antagonists on TGF-beta1-induced fibrosis in transgenic mice.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Dominant negative 14-3-3 promotes cardiomyocyte apoptosis in early stage of type I diabetes mellitus through activation of JNK.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Measurement of protein using bicinchoninic acid

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Inhibition of cardiovascular cell proliferation by angiotensin receptor blockers: are all molecules the same?

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Proteins homologous to p47phox and p67phox support superoxide production by NAD(P)H oxidase 1 in colon epithelial cells

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Arachidonic acid activates c-jun N-terminal kinase through NADPH oxidase in rabbit proximal tubular epithelial cells

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Transforming growth factor-beta inhibition of proteasomal activity: a potential mechanism of growth arrest.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Angiotensin II increases the expression of the transcription factor ETS-1 in mesangial cells.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Kidney fibrosis in hypertensive rats: role of oxidative stress

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Angiotensin-(1-7) prevents diabetes-induced attenuation in PPAR-gamma and catalase activities

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Antioxidative, Antinitrative, and Vasculoprotective Effects of a Peroxisome Proliferator–Activated Receptor-γ Agonist in Hypercholesterolemia

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

The PPARgamma ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice.

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

p38 MAPK and MAPK kinase 3/6 mRNA and activities are increased in early diabetic glomeruli

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2011.560149

21 January 2018

Identifiers

10.3109/10715762.2011.560149

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21381899%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21381899%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42747102&oldid=1579079057"